Exeter V40骨水泥股骨柄至少10年随访:首批540例
报告2000年12月至2002年5月在本中心使用Exeter V40骨水泥股骨柄进行的540例全髋关节置换术的初始结果。随访至少10年,无因无菌性松动翻修股骨柄,13.5年时股骨柄全因翻修Kaplan-Meier生存率为96.8%(95%CI 94.8至98.8),全因翻修(包括髋臼翻修、感染和不稳定)为91.2%(95%CI 88.3至94.1)。
要点
- 540例全髋关节置换术,至少10年随访,无因无菌性松动翻修股骨柄,所有髋均无无菌性松动证据。
- 395例存活股骨柄中374例(94.7%)仍原位,21例(5.3%)固定良好股骨柄翻修。
- 13.5年时股骨柄全因翻修Kaplan-Meier生存率96.8%(95%CI 94.8至98.8)。
核心结论
- 本系列中无股骨柄因无菌性松动而翻修,当代Exeter V40股骨柄继续表现良好,生存率与Exeter Universal股骨柄相当。
研究设计与样本
- 本研究为本中心2000年12月至2002年5月期间使用Exeter V40股骨柄进行的540例全髋关节置换术的初始结果报告。
- 常规方案为术后及术后1年、5年、10年随访。
主要发现
- 145例患者(26.9%)在10年前死亡,剩余395例股骨柄中374例(94.7%)仍原位。
- 21例固定良好股骨柄(5.3%)翻修:10例采用骨水泥内骨水泥技术以便髋臼翻修,3例因感染,1例因不稳定,1例因股骨柄骨折,6例因假体周围骨折。
- 另有16例髋臼组件(4.1%)翻修:5例因无菌性松动,11例因不稳定。
- 无股骨柄因无菌性松动翻修,所有髋均无无菌性松动证据;所有股骨柄结局已知,所有患者仍在随访中。
- 以股骨柄因无菌性松动翻修为终点的生存率为100%;13.5年时股骨柄全因翻修Kaplan-Meier生存率为96.8%(95%CI 94.8至98.8),全因翻修(包括髋臼翻修、感染和不稳定)为91.2%(95%CI 88.3至94.1)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to report the initial results of the Exeter V40 stem, which became available in 2000. PATIENTS AND METHODS: A total of 540 total hip arthroplasties (THAs) were performed in our unit using this stem between December 2000 and May 2002. Our routine protocol is to review patients postoperatively and at one, five, and ten years following surgery. RESULTS: A total of 145 patients (26.9%) died before ten years and of the remaining 395 stems, 374 (94.7%) remain in situ. A total of 21 well-fixed stems (5.3%) were revised. Ten were exchanged using a cement-in-cement technique to facilitate acetabular revision. Three were revised for infection, one for instability, one for fracture of the stem, and six following a periprosthetic fracture. An additional 16 acetabular components (4.1%) were revised; five for aseptic loosening and 11 for instability. There were no revisions for aseptic loosening of the stem, and no evidence of aseptic loosening in any hip. The fate of every stem is known and all patients remain under review. Survivorship, with revision of the stem for aseptic loosening as the endpoint, was 100%. At 13.5 years, the Kaplan-Meier survival rate for all-cause revision of the stem was 96.8% (95% confidence interval (CI) 94.8 to 98.8) and all-cause revision (including acetabular revision, infection, and instability) was 91.2% (95% CI 88.3 to 94.1). CONCLUSION: Conclusion No stem was revised for aseptic loosening in this series. The contemporary Exeter V40 stem continues to perform well, and survival has remained comparable with that of the Exeter Universal stem. Cite this article: Bone Joint J 2018;100-B:1002-9.
引用
- Westerman RW, Whitehouse SL, Hubble MJW, et al. The Exeter V40 cemented femoral component at a minimum 10-year follow-up: the first 540 cases. Bone Joint J. 2018. PMID: 30062940. doi:10.1302/0301-620X.100B8.BJJ-2017-1535.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。